NCT07447076 2026-03-03
Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
University of California, San Francisco
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT06861244 2026-01-07
PNOC031
University of California, San Francisco
Phase 2 Recruiting
NCT07284563 2025-12-16
Ultralow Dose PET Imaging for 18F-NaF Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT07284589 2025-12-16
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
NCT04412629 2025-11-24
Cabozantinib in High Grade Neuroendocrine Neoplasms
Washington University School of Medicine
Phase 2 Active not recruiting
NCT04067726 2025-10-16
TRIDENT
Washington University School of Medicine
Phase 2 Active not recruiting
NCT05692635 2025-09-16
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT06620835 2025-07-29
OPTALK
Groupe Francais De Pneumo-Cancerologie
Phase 2 Recruiting
NCT06904313 2025-06-04
Ultralow Dose PET Imaging for PSMA Expression
Nuclear Imaging Institute
Phase 2 Recruiting
NCT06956391 2025-06-04
Ultralow Dose PET Imaging of 18F-FDG Uptake
Nuclear Imaging Institute
Phase 2 Recruiting